Navigation Links
3SBio Inc. to Present at the UBS Greater China Conference 2012
Date:1/9/2012

SHENYANG, China, Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Mr. Bo Tan, 3SBio's chief financial officer will attend the UBS Greater China Conference 2012 in Shanghai on January 11, 2012. A copy of Mr. Tan's presentation will be archived at www.3sbio.com under the investor relations section.  

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and MP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Investor Contacts


Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
ir@3SBio.com


'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. 3SBio Inc. Announces Results of 2011 Annual General Meeting
2. 3SBio Inc. Announces Unaudited First Quarter 2011 Results
3. 3SBio Inc. Schedules Unaudited First Quarter 2011 Results
4. 3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
5. 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
6. 3SBio Inc. Announces Unaudited Third Quarter Results
7. 3SBio Inc. Announces Unaudited Second Quarter Results
8. 3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
9. 3SBio Inc. Announces Filing of Form 20-F With SEC
10. 3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010
11. 3SBio Announces Changes to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ( ... "Israel Biomedical Sensors Market - Growth, Trends & Forecasts ... The Israel Biomedical Sensors market is estimated at $0.19 ... the period 2014-2020 The near future will ... formulation of each individual. These sensors can be set ...
(Date:8/31/2015)... , Aug. 31, 2015  US-Australian drug discovery ... ) today confirmed its comprehensive scientific review has ... platforms in areas of unmet patient need. Novogen ... remaining preclinical projects prior to entering into Phase ... Acting Chief Executive Officer, Iain ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... as a high priority in the drug development approval process. Thus, innovator companies ... This year, Regis Technologies, Inc., a Chicago-based CMO, has been hosting multiple educational ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Global & USA BioSimilar ... The highly awaited US Biosimilar market will ... awaited filigrastim biologic, Zarxio. How will the global market ... author reveals that biosimilars could save the US economy ...
Breaking Biology Technology:Israel Biomedical Sensors Market 2015 - Growth, Trends & Forecasts to 2020 2Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3
... 2012 Novartis Pharmaceuticals Corporation (NPC) and Sanford Wittels & ... announced an agreement to resolve the nationwide Wage and Hour ... Court for the Southern District of New York.  ... provide a payment of up to 99 million dollars for ...
... BETHESDA, Md., Jan. 24, 2012 The National Foundation ... and Dr. Zhu Chen have been awarded the 7th ... their innovative research that led to the successful development ... (APL).  By combining traditional Chinese medicine ...
... Members of a University of Pennsylvania research team have shown ... disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs. The ... the RPGR gene and results in early, severe and progressive ... forms of retinal degeneration in man. "Every single ...
Cached Biology Technology:Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims 2Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims 3Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims 4Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research 2Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research 3Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research 4Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research 5Gene therapy research from Penn Vet & Scheie Eye Inst. cures retinitis pigmentosa in dogs 2Gene therapy research from Penn Vet & Scheie Eye Inst. cures retinitis pigmentosa in dogs 3
(Date:8/4/2015)... , Aug. 04, 2015 ... http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition of ... (Hardware, Software, and Service), Sub-Segment (Computer Forensics, ... Forensics), Tool Types, Service, Vertical and Region ... to their offering. By Component ...
(Date:8/3/2015)... , Aug. 3, 2015 Synaptics, Inc. ... interface solutions, today announced that members of the executive ... the Pacific Crest Global Technology Leadership Forum on Tuesday, ... conference will be held at the Sonnenalp Resort in ... The presentation may include forward-looking information. An audio webcast ...
(Date:7/31/2015)... , 31 de julio de 2015 ... (ICG-10,  www.icg-10.org ) del 22 al 25 de octubre ... La conferencia celebra su décimo aniversario este ... convertido en una de las reuniones anuales más influyentes ... es una de las conferencias científicas más dinámicas, entusiastas ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... at MIT recently found an elegant solution to a ... doesn,t soak into soil at an even rate, but ... downward. Scientists call these rivulets "gravity fingers," ... with the surface tension where the wateror any liquidmeets ...
... playing a major role in a 4m European project to ... animal feed. Professor Chris Elliott, Director of the Institute ... team of scientists in developing new tests aimed to protect ... of foods including meat, poultry, milk, seafood and cereals. ...
... thousands of families is helping prospective parents work out whether ... work by Corry Gellatly, a research scientist at the university, ... sons or more daughters from their parents. This means that ... sons, while a man with many sisters is more likely ...
Cached Biology News:MIT researchers explain mystery of gravity fingers 2Queen's University Belfast plays leading role in Europe-wide tests for safer food 2Boy or girl? It's in the father's genes 2Boy or girl? It's in the father's genes 3